mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-07 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.006 |
0.8 |